10 citations
,
March 2018 in “Anais Brasileiros De Dermatologia”
This study observed that androgenetic alopecia had a more significant negative impact on psychological parameters in females than males, with some differences in psychosexual outcomes based on clinical stages.
October 2021 in “DOAJ (DOAJ: Directory of Open Access Journals)”
In this hospital-based cross-sectional study, researchers observed that trichoscopy effectively differentiates between severe and mild male pattern hairloss by identifying specific features such as yellow and white dots, vellus hair, and hair shaft diversity.
In this study, researchers examined men with early-stage androgenetic alopecia and found distinct patterns of hairloss correlated with genetic and hormonal factors, noting that parietal region pattern hairloss responded better to minoxidil and micronutrient treatment compared to occipital region pattern.
November 2021 in “Journal of The American Academy of Dermatology”
This study found that advanced stages of female pattern hairloss are associated with increased age, menopausal state, and hypertension, while acne vulgaris is more prevalent in earlier stages.
Can a zinc deficiency directly cause hair thinning or increased shedding?Studies link low serum zinc to diffuse shedding and alopecia areata, and severe deficiency states cause hair loss that reverses when zinc is replaced. The evidence is mostly observational, the one supplementation study was small and uncontrolled, and zinc is not a treatment for pattern hair loss.
A user with stage 3 baldness is seeking advice on microneedling for hair growth, including pre and post-care, washing routines, and the use of hair growth serums or oils. They also inquire about the effectiveness and safety of microneedling pens.
Various peptides are discussed for treating male pattern baldness, with some available for topical use like GHK-Cu and Ac-KGHK, while others remain in research stages. Users are interested in experiences and sourcing these treatments.
Redensyl is a plant-based treatment that may support hair regrowth by reactivating dormant follicles and improving hair density, especially in early-stage thinning. It is not a miracle cure and results vary; it is less proven than Minoxidil or Finasteride and may cause scalp irritation.
CRISPR shows promise for treating hairloss by targeting specific genes. Current treatments include Minoxidil and finasteride, but CRISPR could offer a more precise solution, though it is still expensive and in early stages.
The user has been using topical finasteride for seven months and minoxidil for three years, with added tretinoin gel for ten months, and is experiencing continuous shedding without signs of regrowth. They are questioning if the amount of shedding is normal at this stage of treatment and if there's a correlation between finasteride response and the rate of hairloss.